Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Troponin I Antikörper (AA 186-192)

Der Maus Monoklonal Anti-Troponin I-Antikörper wurde für WB, ELISA, IHC und IP validiert. Er ist geeignet, Troponin I in Proben von Human zu detektieren. Es sind 5+ Publikationen verfügbar.
Produktnummer ABIN284801

Kurzübersicht für Troponin I Antikörper (AA 186-192) (ABIN284801)

Target

Alle Troponin I (TNNI) Antikörper anzeigen
Troponin I (TNNI)

Reaktivität

  • 48
  • 19
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
Human

Wirt

  • 35
  • 27
  • 2
Maus

Klonalität

  • 37
  • 27
Monoklonal

Konjugat

  • 30
  • 7
  • 5
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Troponin I Antikörper ist unkonjugiert

Applikation

  • 49
  • 36
  • 22
  • 13
  • 13
  • 11
  • 8
  • 7
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)

Klon

C5
  • Bindungsspezifität

    • 15
    • 15
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 186-192

    Aufreinigung

    purified

    Immunogen

    Troponin I antibody (cardiac) was raised in mouse using amino acid residues 186-192 of cTnI as the immunogen.

    Isotyp

    IgG2b
  • Applikationshinweise

    Optimal conditions should be determined byt he investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    Lot specific

    Buffer

    Protein A purified and supplied in PBS, pH 7.4, 0.1 % NaN3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    4 °C
  • Lin, Schmidt, Fritz, Jeong, Cammarato, Foster, Biesiadecki, McKinsey, Woulfe: "Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity." in: Journal of molecular and cellular cardiology, Vol. 139, pp. 135-147, (2020) (PubMed).

    Waas, Weerasekera, Kropp, Romero-Tejeda, Poon, Boheler, Burridge, Gundry: "Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry." in: Stem cell reports, Vol. 12, Issue 2, pp. 395-410, (2020) (PubMed).

    Woulfe, Ferrara, Pioner, Mahaffey, Coppini, Scellini, Ferrantini, Piroddi, Tesi, Poggesi, Jeong: "A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study." in: Frontiers in cardiovascular medicine, Vol. 6, pp. 12, (2019) (PubMed).

    Lin, Warren, Li, McKinsey, Russell: "Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ." in: Cellular signalling, Vol. 28, Issue 8, pp. 1015-24, (2017) (PubMed).

    Scruggs, Walker, Lyu, Geenen, Solaro, Buttrick, Goldspink: "Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation." in: Journal of molecular and cellular cardiology, Vol. 40, Issue 4, pp. 465-73, (2006) (PubMed).

  • Target

    Troponin I (TNNI)

    Andere Bezeichnung

    Troponin I
Sie sind hier:
Chat with us!